Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spain promotes nationwide glaucoma screening:

This article was originally published in Clinica

Executive Summary

Spain last week held a nationwide free glaucoma screening campaign. 1,500 specialists in around 800 centres supported the initiative, with the aim of increasing awareness of the importance of early diagnosis in tackling the disease. Ophthalmotonometry - the measurement of intraocular pressure - can provide an early indication of the potential onset and extent of glaucoma, which is the main cause of blindness in Spain. The condition is avoidable if treated early. Screening for glaucoma should be performed routinely as part of every eye-sight test from around 35-40 years of age, Spanish ophthalmological experts believe.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT075257

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel